Drug Type Polysaccharide |
Synonyms GLP |
Target |
Action activators, stimulants |
Mechanism HMOX1 activators(Heme oxygenase 1 activators), Nrf2 stimulants(Nuclear factor erythroid 2-related factor 2 stimulants), SOD activators(Superoxide dismutases activators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Reperfusion Injury | Preclinical | China | 28 Nov 2025 |





